Picture of Charles River Laboratories International logo

CRL Charles River Laboratories International Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Charles River Laboratories International, fiscal year end - December 30th, USD millions except per share, conversion factor applied.

2019
December 28th
2020
December 26th
2021
December 25th
2022
December 31st
2023
December 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue2,6212,9243,5403,9764,129
Cost of Revenue
Gross Profit9581,0741,3351,4631,529
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses2,2702,4912,9283,3053,389
Operating Profit351433613671741
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes304447481623581
Provision for Income Taxes
Net Income After Taxes254365399493480
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income252364391486475
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income252364391486475
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS5.717.637.989.37.92